Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
2nd dose of vaccine not received; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 53-year-old male patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on 23-SEP-2023). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: 2nd dose of vaccine not received). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 07-OCT-2025 A pharmacist reported that the patient did not receive the 2nd dose of Shingrix yet. The reporter enquired if they should give the 2nd dose or restart the series. The batch number was not provided upon follow- up with the reporter.